| RS1057524139 |
RERE
|
Health Risk |
Likely pathogenic |
— |
| RS1057524140 |
PGK1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524142 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS1057524147 |
TLK2
|
Health Risk |
Likely pathogenic |
— |
| RS1057524152 |
FOXP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Inborn genetic diseases |
| RS1057524153 |
ATRX
|
Health Risk |
Likely pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS1057524155 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1057524157 |
DEAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS1057524158 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1057524160 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1057524163 |
COL5A2
|
Health Risk |
Likely pathogenic |
— |
| RS1057524164 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1057524165 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1057524171 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1057524176 |
SLC26A4
|
Health Risk |
Pathogenic |
— |
| RS1057524183 |
NARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 24, Combined oxidative phosphorylation defect type 24 |
| RS1057524191 |
TBC1D24
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 65, Developmental and epileptic encephalopathy |
| RS1057524192 |
TBC1D24
|
Health Risk |
Likely pathogenic |
TBC1D24-related disorder, Autosomal dominant nonsyndromic hearing loss 65 |
| RS1057524193 |
KIF5A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 10, Myoclonus |
| RS1057524195 |
KAT6A
|
Health Risk |
Pathogenic |
— |
| RS1057524203 |
DST
|
Health Risk |
Pathogenic |
— |
| RS1057524205 |
SATB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1057524208 |
SMARCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1057524217 |
MED12
|
Health Risk |
Likely pathogenic |
Nonspecific Intellectual Disability, Nonspecific Intellectual Disability |
| RS1057524233 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Epilepsy |
| RS1057524234 |
DYNC2H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Inborn genetic diseases |
| RS1057524237 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marshall syndrome, Marshall syndrome |
| RS1057524239 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Dilated cardiomyopathy 1NN |
| RS1057524241 |
KAT6B
|
Health Risk |
Pathogenic |
— |
| RS1057524248 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS1057524250 |
PLOD2
|
Health Risk |
Likely pathogenic |
— |
| RS1057524251 |
PLOD2
|
Health Risk |
Pathogenic |
— |
| RS1057524256 |
PIGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Inborn genetic diseases |
| RS1057524257 |
IFIH1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524261 |
PDP1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524265 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS1057524290 |
SCN4A
|
Health Risk |
Likely pathogenic |
— |
| RS1057524291 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS1057524293 |
DIAPH1
|
Health Risk |
Pathogenic |
— |
| RS1057524298 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1057524302 |
HECW2
|
Health Risk |
Likely pathogenic |
— |
| RS1057524307 |
ELOVL4
|
Health Risk |
Pathogenic |
— |
| RS1057524308 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS1057524314 |
RPS6KA3
|
Health Risk |
Pathogenic |
— |
| RS1057524317 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1057524339 |
CHD8
|
Health Risk |
Pathogenic |
Glioma susceptibility 1, Glioma susceptibility 1 |
| RS1057524340 |
KAT6A
|
Health Risk |
Pathogenic |
— |
| RS1057524341 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1057524343 |
TBL1XR1
|
Health Risk |
Pathogenic |
Pierpont syndrome, Pierpont syndrome |
| RS1057524355 |
ALS2
|
Health Risk |
Likely pathogenic |
— |
| RS1057524364 |
DARS2
|
Health Risk |
Likely pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS1057524366 |
MPV17
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) |
| RS1057524378 |
FLNA
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS1057524379 |
HDAC8
|
Health Risk |
Likely pathogenic |
— |
| RS1057524385 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fumarase deficiency |
| RS1057524391 |
ARID2
|
Health Risk |
Pathogenic |
— |
| RS1057524392 |
GRIN2B
|
Health Risk |
Pathogenic |
— |
| RS1057524393 |
RPS6KA3
|
Health Risk |
Likely pathogenic |
— |
| RS1057524398 |
FBN2
|
Health Risk |
Pathogenic |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS1057524408 |
NONO
|
Health Risk |
Pathogenic |
— |
| RS1057524415 |
GABRB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, childhood absence |
| RS1057524419 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1057524426 |
IGF1R
|
Health Risk |
Pathogenic |
— |
| RS1057524427 |
NIPBL
|
Health Risk |
Likely pathogenic |
— |
| RS1057524433 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1057524434 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontometaphyseal dysplasia, Heterotopia |
| RS1057524439 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1057524442 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS1057524444 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1057524447 |
SCN5A
|
Health Risk |
Likely pathogenic |
Cervical cancer, Cervical cancer |
| RS1057524458 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1057524460 |
PYCR1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524466 |
FOXN1
|
Health Risk |
Likely pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS1057524468 |
CAPN3
|
Health Risk |
Likely pathogenic |
Muscular dystrophy, limb-girdle |
| RS1057524473 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS1057524476 |
SPINK5
|
Health Risk |
Pathogenic |
— |
| RS1057524479 |
HNF1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal cysts and diabetes syndrome, Maturity-onset diabetes of the young |
| RS1057524482 |
WAC
|
Health Risk |
Pathogenic/Likely pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS1057524483 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1057524485 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS1057524490 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1057524497 |
TGFBR1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1057524499 |
GAMT
|
Health Risk |
Likely pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS1057524501 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1057524504 |
PNPO
|
Health Risk |
Likely pathogenic |
— |
| RS1057524506 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1057524508 |
UBE3A
|
Health Risk |
Likely pathogenic |
— |
| RS1057524509 |
TCF12
|
Health Risk |
Likely pathogenic |
— |
| RS1057524511 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1057524512 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1057524526 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia |
| RS1057524546 |
FGFR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pfeiffer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS1057524547 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS1057524549 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1057524557 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1057524559 |
SMARCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1057524560 |
HUWE1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524561 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 31A |
| RS1057524563 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1057524571 |
MEN1
|
Health Risk |
Likely pathogenic |
— |